SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow of -$14.22M in Q1 FY2026

Q1 FY2026 free cash flow was -$14.22M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$14.22M+45.8% QoQ
Last fiscal yearDec 2025
-$33.49M— YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
(33.49M) USD
Year-over-year change
—

Free Cash Flow vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Free Cash Flow for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$1.76B USD+19.7%+50.5%16.1%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$271.54M USD+79.5%+53.6%3565.9%
OCULOcular Therapeutix, Inc.LTM Mar 2026$240.94M USD+62.3%+50.7%463.0%
BLCOBausch + Lomb CorporationLTM Jun 2026$140.33M USD+185.0%—2.6%
OCSOculis Holding AGLTM Mar 2026CHF 62.47M CHF+14.4%+29.7%12395.4%
STAASTAAR Surgical CompanyLTM Apr 2026$54.99M USD+301.9%—18.9%
SGPSpyGlass Pharma, Inc. Common StockFY2025$33.49M USD———
SGHTSight Sciences, Inc.LTM Mar 2026$25.4M USD+3.9%-27.0%31.9%
RXSTRxSight, Inc.LTM Mar 2026$21.58M USD+5.2%-31.9%16.9%
GKOSGlaukos CorporationLTM Jun 2026$12.2M USD-54.7%-5.2%2.0%
Peer median (excluding SGP) —+19.7%+29.7%18.9%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.